Using open models is still a novel idea for most companies, but I’ve had the fortune of interacting with a few leaders who have been experimenting with open models in business for more than a decade.

Advances in biofabrication and 3D in vitro model systems are transforming biomedical research, drug development, and toxicity testing. However, despite ...

The lack of common standards and problems with reproducing and verifying existing datasets are widespread in the biotech community. However, a new tool named Memote paves the way for quality testing ...